0001209191-14-071977.txt : 20141201
0001209191-14-071977.hdr.sgml : 20141201
20141201171029
ACCESSION NUMBER: 0001209191-14-071977
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141128
FILED AS OF DATE: 20141201
DATE AS OF CHANGE: 20141201
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SACHS BRUCE I
CENTRAL INDEX KEY: 0001197036
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 141258439
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-11-28
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197036
SACHS BRUCE I
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2014-11-28
4
M
0
10000
28.40
A
31210
D
Common Stock
2014-11-28
4
S
0
10000
120.03
D
21210
D
Stock Option (right to buy)
28.40
2014-11-28
4
M
0
10000
0.00
D
2018-05-31
Common Stock
10000
10000
D
Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $120.03 (range $120.00 to $120.15).
Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Fully vested.
Omar White, Attorney-In-Fact
2014-12-01